Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by DerekForealon Dec 05, 2016 7:52pm
109 Views
Post# 25557643

RE:RE:Potential correction to $15+ tomorrow

RE:RE:Potential correction to $15+ tomorrow Nonetheless I made 2.4k in profit today. What about you? You obviously don't follow the company and understand anything about it. Investors were pricing by news incc, but nothing negative came out. In fact, everything looks under control and positive. The sp target is 22usd and we will get there retail is heavily invested and balance sheet is 10x stronger than any comp. gltme 
Bullboard Posts